Us Bancorp \De\ Neuro Pace Inc Transaction History
Us Bancorp \De\
- $74.1 Billion
- Q1 2025
A detailed history of Us Bancorp \De\ transactions in Neuro Pace Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 327 shares of NPCE stock, worth $3,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
327Holding current value
$3,822% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NPCE
# of Institutions
73Shares Held
21.9MCall Options Held
23.2KPut Options Held
800-
Kck Ltd. Tortola, D85.27MShares$61.6 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$39.8 Million1.03% of portfolio
-
Morgan Stanley New York, NY2.49MShares$29.1 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$28.4 Million1.9% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.48MShares$17.3 Million7.02% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $290M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...